Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neisseria meningitidis Capsular Polysaccharides Serogroup C (MenC CPS)
- Target
- MenC CPS
- Molecular classification
- Polysaccharide, Capsular Polysaccharide
01
Overview
The capsular polysaccharide of Neisseria meningitidis serogroup C, composed primarily of α(2→9)-linked N-acetylneuraminic acid, is a critical virulence factor enabling immune evasion. It serves as the primary antigenic target for both polysaccharide and conjugate vaccines aimed at preventing invasive meningococcal disease caused by this serogroup.
- Other names
- Serogroup C capsular polysaccharideMenC polysaccharideN. meningitidis serogroup C capsule
02
Mechanism of action
Antibody-mediated complement activation and opsonization, induction of long-lasting immunity
03
Biological functions
Immune evasionAnti-phagocytic barrierVirulence factor
04
Disease associations
MeningitisSepticemiaInvasive meningococcal disease
05
Safety considerations
Vaccine side effects (e.g., fever, local reactions)Potential for capsular switching
06
Interacting drugs
Anti-MenC antibodies
4 more in the full profile.
07
Biomarkers
Anti-MenC antibody titersCapsular polysaccharide C presence
Beyond the preview
Go deeper on Neisseria meningitidis Capsular Polysaccharides Serogroup C (MenC CPS).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neisseria meningitidis Capsular Polysaccharides Serogroup C (MenC CPS).